Literature DB >> 16772154

Endometrium in PCOS: Implantation and predisposition to endocrine CA.

Linda C Giudice1.   

Abstract

Polycystic ovarian syndrome (PCOS) is a common endocrinopathy characterized by oligo/anovulatiaon and elevated circulating androgens or evidence of hyperandrogenism after all known potential causes have been excluded. In addition, insulin resistance and accompanying hyperinsulinemia commonly occur in women with PCOS. There is increasing evidence that the endocrinologic and metabolic abnormalities in PCOS may have complex effects on the endometrium, contributing to the infertility and endometrial disorders observed in women with this syndrome. Androgen receptors and steroid receptor co-activators are over-expressed in the endometrium of women with PCOS. Also, biomarkers of endometrial receptivity to embryonic implantation-such as alpha(v)beta3-integrin and glycodelin-are decreased, and epithelial expression of estrogen receptor alpha (ERalpha) abnormally persists in the window of implantation in endometrium in women with PCOS. In addition to being responsive to the steroid hormones estradiol, progesterone, and androgens, the endometrium is also a target for insulin, the receptor for which is cyclically regulated in normo-ovulatory women. In vitro, insulin inhibits the normal process of endometrial stromal differentiation (decidualization). In addition, insulin-like growth factors (IGFs) and their binding proteins are regulated in and act on endometrial cellular constituents, and hyperinsulinemia down-regulates hepatic IGFBP-1, resulting in elevated free IGF-I in the circulation. Thus, elevated estrogen (without the opposing effects of progesterone in the absence of ovulation), hyperinsulinemia, elevated free IGF-I and androgens, and obesity all likely contribute to endometrial dysfunction, infertility, increased miscarriage rate, endometrial hyperplasia, and endometrial cancer common in women with PCOS. The potential mechanisms underlying these disorders, specifically in women with PCOS, are complex and await additional transdisciplinary research for their complete elucidation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16772154     DOI: 10.1016/j.beem.2006.03.005

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  75 in total

Review 1.  Implantation failure: molecular mechanisms and clinical treatment.

Authors:  Hakan Cakmak; Hugh S Taylor
Journal:  Hum Reprod Update       Date:  2010-08-21       Impact factor: 15.610

2.  Dietary insulin index and insulin load in relation to endometrial cancer risk in the Nurses' Health Study.

Authors:  Jennifer Prescott; Ying Bao; Akila N Viswanathan; Edward L Giovannucci; Susan E Hankinson; Immaculata De Vivo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-05-23       Impact factor: 4.254

3.  cAMP-Response Element-Binding 3-Like Protein 1 (CREB3L1) is Required for Decidualization and its Expression is Decreased in Women with Endometriosis.

Authors:  J I Ahn; J-Y Yoo; T H Kim; Y I Kim; S D Ferguson; A T Fazleabas; S L Young; B A Lessey; J Y Ahn; J M Lim; J-W Jeong
Journal:  Curr Mol Med       Date:  2016       Impact factor: 2.222

4.  Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome.

Authors:  A Villavicencio; A Goyeneche; C Telleria; K Bacallao; F Gabler; A Fuentes; M Vega
Journal:  Gynecol Oncol       Date:  2009-07-23       Impact factor: 5.482

Review 5.  Genetics and Epigenetics of Infertility and Treatments on Outcomes.

Authors:  Margareta D Pisarska; Jessica L Chan; Kate Lawrenson; Tania L Gonzalez; Erica T Wang
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

6.  Transcriptional profiling with a pathway-oriented analysis identifies dysregulated molecular phenotypes in the endometrium of patients with polycystic ovary syndrome.

Authors:  Jin Yeong Kim; Haengseok Song; Hyunjoo Kim; Hee Jung Kang; Jin Hyun Jun; Sung Ran Hong; Mi Kyoung Koong; In Sun Kim
Journal:  J Clin Endocrinol Metab       Date:  2009-01-13       Impact factor: 5.958

7.  Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes.

Authors:  Hannah P Yang; Jesus Gonzalez Bosquet; Qizhai Li; Elizabeth A Platz; Louise A Brinton; Mark E Sherman; James V Lacey; Mia M Gaudet; Laurie A Burdette; Jonine D Figueroa; Julia G Ciampa; Jolanta Lissowska; Beata Peplonska; Stephen J Chanock; Montserrat Garcia-Closas
Journal:  Carcinogenesis       Date:  2010-01-06       Impact factor: 4.944

8.  Proinflammatory environment and role of TNF-α in endometrial function of obese women having polycystic ovarian syndrome.

Authors:  L Oróstica; I Astorga; F Plaza-Parrochia; C Vera; V García; R Carvajal; F Gabler; C Romero; M Vega
Journal:  Int J Obes (Lond)       Date:  2016-08-29       Impact factor: 5.095

9.  Glucosamine inhibits decidualization of human endometrial stromal cells and decreases litter sizes in mice.

Authors:  Jui-He Tsai; Maureen Schulte; Kathleen O'Neill; Maggie M-Y Chi; Antonina I Frolova; Kelle H Moley
Journal:  Biol Reprod       Date:  2013-07-25       Impact factor: 4.285

10.  Assessment of ultrasonographic features of polycystic ovaries is associated with modest levels of inter-observer agreement.

Authors:  Marla E Lujan; Donna R Chizen; Andrew K Peppin; Anita Dhir; Roger A Pierson
Journal:  J Ovarian Res       Date:  2009-06-10       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.